# Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer

> **NCT03336567** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 40 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **OTHER:** Telephonic interview

## Key facts

- **NCT ID:** NCT03336567
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-04
- **Primary completion:** 2018-06-12
- **Final completion:** 2018-06-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03336567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03336567, "Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03336567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*